How has been the historical performance of SMS Pharma.?
SMS Pharma has shown significant growth in net sales and profits, with net sales rising from 522.05 Cr in Mar'23 to 782.75 Cr in Mar'25, and net profit recovering from -7.06 Cr to 69.14 Cr during the same period, indicating strong operational efficiency and enhanced shareholder value.
Answer:The historical performance of SMS Pharma shows a significant upward trend in net sales and profits over the past few years.Breakdown:
SMS Pharma's net sales increased from 522.05 Cr in Mar'23 to 782.75 Cr in Mar'25, reflecting a strong growth trajectory. The total operating income followed a similar pattern, rising from 522.05 Cr in Mar'23 to 782.75 Cr in Mar'25. The company's total expenditure also grew, from 467.57 Cr in Mar'23 to 643.75 Cr in Mar'25, driven primarily by higher raw material costs, which increased from 299.72 Cr in Mar'23 to 501.87 Cr in Mar'25. Operating profit, excluding other income, rose from 54.48 Cr in Mar'23 to 139.00 Cr in Mar'25, indicating improved operational efficiency. Profit before tax surged from 5.35 Cr in Mar'23 to 92.34 Cr in Mar'25, while profit after tax increased from 3.88 Cr in Mar'23 to 67.40 Cr in Mar'25. The net profit also showed a remarkable recovery, moving from -7.06 Cr in Mar'23 to 69.14 Cr in Mar'25. Earnings per share (EPS) improved significantly, from -0.83 in Mar'23 to 7.79 in Mar'25, demonstrating the company's enhanced profitability and shareholder value. Overall, SMS Pharma's financial performance indicates a robust recovery and growth in both revenue and profitability over the analyzed period.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
